TrialCancer research2010

Plasma cytokine and angiogenic factor profiling identifies markers associated with tumor shrinkage in early-stage non-small cell lung cancer patients treated with pazopanib.

Petros G Nikolinakos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.